Characterization of a human apolipoprotein a-I construct expressed in a bacterial system

Area of Science:

• Biochemistry
• Cardiovascular Science
• Protein Engineering

Background:

• Apolipoprotein A-I (apoA-I) is crucial for high-density lipoprotein (HDL) function and metabolism.
• Low apoA-I levels correlate with increased atherosclerosis and cardiovascular disease risk.
• Efficient production of recombinant apoA-I is needed for research and therapeutic development.

Purpose of the Study:

• To characterize a bacterial recombinant apolipoprotein A-I (apoA-I) variant.
• To compare the properties of the recombinant apoA-I variant with native human apoA-I.
• To validate the utility of the recombinant apoA-I variant for future research and applications.

Main Methods:

• Bacterial expression system for producing a truncated apoA-I variant.
• Biochemical and biophysical characterization of the recombinant apoA-I.
• Comparative analysis of the recombinant variant against serum-derived apoA-I.

Main Results:

• A bacterial expression method successfully produced an apoA-I variant lacking N-terminal residues.
• The characterized apoA-I variant demonstrated properties comparable to native human apoA-I.
• The findings support the suitability of this recombinant variant.

Conclusions:

• The N-terminally truncated apoA-I variant produced via bacterial expression is a viable substitute for native apoA-I.
• This recombinant apoA-I variant holds promise for applications in basic research and pharmacological therapy.
• Further investigations and assays can confidently utilize this validated recombinant apoA-I.